Evidence map›Paper›PMID 27277075›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2016

Glycemic Response to Corn Starch Modified with Cyclodextrin Glycosyltransferase and its Relationship to Physical Properties.

A Dura, W Yokoyama, C M Rosell

Abstract read
PubMed Publisher
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

A DuraInstitute of Agrochemistry and Food Technology (IATA-CSIC), Avenida Agustin Escardino, 7, 46980, Paterna, Valencia, Spain.
W YokoyamaHealthy Processed Foods Research, Agricultural Research Service, U.S. Department of Agriculture, Albany, California, 94710, USA.
C M RosellInstitute of Agrochemistry and Food Technology (IATA-CSIC), Avenida Agustin Escardino, 7, 46980, Paterna, Valencia, Spain. crosell@iata.csic.es.
Agricultural Research Service · USInstituto de Agroquímica y Tecnología de Alimentos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corn starch was modified with cyclodextrin glycosyltransferase (CGTase) below the gelatinization temperature. The porous granules with or without CGTase hydrolysis products may be used as an alternative to modified corn starches in foods applications. The amount and type of hydrolysis products were determined, containing mainly β-cyclodextrin (CD), which will influence pasting behavior and glycemic response in mice. Irregular surface and small holes were observed by microscopic analysis and differences in pasting properties were observed in the presence of hydrolysis products. Postprandial blood glucose in mice fed gelatinized enzymatically modified starch peaked earlier than their ungelatinized counterparts. However, in ungelatinized enzymatically modified starches, the presence of β- CD may inhibit the orientation of amylases slowing hydrolysis, which may help to maintain lower blood glucose levels. Significant correlations were found between glycemic curves and viscosity pattern of starches.

Indexed as

Glycemic IndexAmylasesAnimalsbeta-CyclodextrinsBlood GlucoseGlucose Tolerance TestGlucosyltransferasesHydrolysisMaleMiceMice, Inbred C57BLMicroscopy, Electron, ScanningPostprandial PeriodStarchTemperatureViscosityAmylasesbeta-CyclodextrinsBlood Glucosecyclomaltodextrin glucanotransferaseGlucosyltransferasesStarchCGTaseCorn starchCyclodextrinsEnzymatic modificationGlucose response

Identifiers

PMID27277075
OpenAlexW2409687524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.